Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clene Inc. - Common Stock (NQ:CLNN)

5.620 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,458
Open 5.620
Bid (Size) 5.480 (3)
Ask (Size) 5.500 (1)
Prev. Close 5.620
Today's Range 5.620 - 5.620
52wk Range 2.280 - 6.900
Shares Outstanding 128,404,735
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results, Targets Year-End NDA Submission for ALS Therapy
Via Investor Brand Network

Performance

YTD
+4.3%
+4.3%
1 Month
+45.2%
+45.2%
3 Month
+124.8%
+124.8%
6 Month
+18.6%
+18.6%
1 Year
+8.1%
+8.1%

More News

Read More
Clene Posts 70% Revenue Drop in Q2
Via The Motley Fool
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
Via Investor Brand Network
Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option
Via Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
Via Investor Brand Network
New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate
Via Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Individuals Who Develop Multiple Sclerosis Have More Doctor Visits Decades Before Their Diagnosis
Via Investor Brand Network
Preclinical Study Finds a Way to Reverse Symptoms of Parkinson’s in Mice
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
Via Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
Via Investor Brand Network
Why Public Interest in Mitochondrial Function Testing is Growing
Via Investor Brand Network
Q2 Virtual Investor Summit: Presentations Available Now
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
Via Stocktwits
Study Finds Kids with MS Biologically Age Faster Than Those Without It
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Rob Etherington to Present at June 10 Investor Summit Virtual
Via Investor Brand Network
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Study Links Autism to Increased Risk of Developing Parkinson’s Disease
Via Investor Brand Network

Frequently Asked Questions

Is Clene Inc. - Common Stock publicly traded?
Yes, Clene Inc. - Common Stock is publicly traded.
What exchange does Clene Inc. - Common Stock trade on?
Clene Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Clene Inc. - Common Stock?
The ticker symbol for Clene Inc. - Common Stock is CLNN on the Nasdaq Stock Market
What is the current price of Clene Inc. - Common Stock?
The current price of Clene Inc. - Common Stock is 5.620
When was Clene Inc. - Common Stock last traded?
The last trade of Clene Inc. - Common Stock was at 08/20/25 04:00 PM ET
What is the market capitalization of Clene Inc. - Common Stock?
The market capitalization of Clene Inc. - Common Stock is 721.63M
How many shares of Clene Inc. - Common Stock are outstanding?
Clene Inc. - Common Stock has 722M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.